Blueshift Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-31,910	Closed	-$442K	–	833
2021 Q4	$442K	Buy	31,910 +11,348	+55%	+$157K	0.04%	517
2021 Q3	$295K	Buy	+20,562	New	+$295K	0.02%	822
2021 Q2	–	Sell	-57,655	Closed	-$586K	–	918
2021 Q1	$586K	Buy	+57,655	New	+$586K	0.06%	427